Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Olympus Corp (7733 JP): Positive Q4FY26 Stabilizes FY26, FY27 Guidance Signals Gradual Recovery

Olympus Corp (7733 JP): Q1FY27 Shines, Guidance Reiterated, Recovery On Track

Olympus Corp (7733 JP): Forex Holds FY25 Together; FY26 Guidance Does Not Offer Much Respite

Olympus Corp (7733 JP): A Much-Awaited Turnaround On the Cards? One Quarter At a Time

Olympus Corp (7733 JP): Concerns Remain; Green Shoots Appear; Better To Wait and Watch

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/olympus-corp" target="_blank" data-smartkarma-citation="entities:356:1" rel="noopener">Olympus Corp (7733 JP)</a> registered 1% YoY decline in revenue to ¥715.4B in 9MFY26 while the adjusted operating profit witnessed 183% YoY decrease to ¥89.9B (margin down 510bps to 12.6%).</li>
<li>The company partially revised full-year forecasts for FY26. The company expects profits to be further lower than previous guidance due to ship holds in Surgical division.</li>
<li>The Q3FY26 results showed certain improvements that will help the company take positive step forward. We would prefer to stay on the sidelines and watch for the time being.</li>
</ul>



Olympus Corp (7733 JP) registered 1% YoY decline in revenue to ¥715.4B in 9MFY26 while the adjusted operating profit witnessed 183% YoY decrease to ¥89.9B (margin down 510bps to 12.6%).
The company partially revised full-year forecasts for FY26. The company expects profits to be further lower than previous guidance due to ship holds in Surgical division.
The Q3FY26 results showed certain improvements that will help the company take positive step forward. We would prefer to stay on the sidelines and watch for the time being.


Olympus Corp (7733 JP): Turnaround Will Take Some Time, Company Taking Positive Baby Steps For Now